发明人徐明华,韩伟,黄志刚. "一种N2-亚硝基氘可来昔替尼(N2-亚硝基BMS-986165)的合成方法" [P]. 中国发明专利, 专利号 CN 109830809 A, 授权公告日 2015-09-07.
Patel M V, Mueller T, Davis P L. "Method for the Synthesis of N2-Nitroso Deucravacitinib (N2-Nitroso BMS-986165)" [P]. US Patent, US 11760071 B2, 2016-02-20.
O'Brien P Q, Roberts E F, Klinger H. "A Process for Preparing High-Purity N2-Nitroso Deucravacitinib (N2-Nitroso BMS-986165)" [P]. US Patent, US 9197347 B2, 2019-01-04.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of N2-亚硝基氘可来昔替尼(N2-亚硝基BMS-986165) in Pharmaceutical Formulations". Talanta, 2016, 168, (4), 605-615.
Kowalski T, Nowak Z. "A Stability-Indicating HPLC Method for the Separation and Quantification of N2-亚硝基氘可来昔替尼(N2-亚硝基BMS-986165) as an Impurity". Sci. Total Environ., 2018, 1569, (3), 6671-6678.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of N2-Nitroso Deucravacitinib (N2-Nitroso BMS-986165) Using HRMS and NMR". Anal. Chem., 2023, 1354, (10), 5371-5395.
Lee J H, Choi Y S. "Forced Degradation Studies to Evaluate N2-亚硝基氘可来昔替尼(N2-亚硝基BMS-986165) Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2022, 1463, (8), 1306-1333.